Medindia

X

Diclofenac Gel from Glenmark Pharmaceuticals Receives FDA Approval

by Madhumathi Palaniappan on  September 15, 2016 at 12:41 PM Drug News   - G J E 4
Diclofenac Sodium gel for skin lesion treatment from Glenmark Pharmaceuticals has recently been approved by the United States Food and Drug Administration.
Diclofenac Gel from Glenmark Pharmaceuticals Receives FDA Approval
Diclofenac Gel from Glenmark Pharmaceuticals Receives FDA Approval
Advertisement

"Glenmark Pharmaceuticals Inc USA has been granted final approval by the USFDA for Diclofenac Sodium gel, 3 per cent, the generic version of Solaraze gel, 3 per cent," the company said in a BSE filing.

‘Glenmark Pharmaceuticals receives FDA approval for diclofenac sodium gel.’
Advertisement
"According to IMS Health sales data for the 12-month period ending July 2016, the Solaraze Gel, 3 per cent market achieved annual sales of approximately $297.9 million," it said.

Glenmark's current portfolio consists of 110 products authorised for distribution in the US marketplace and 61 Abbreviated New Drug Applications (ANDAs) are pending for approval with the USFDA.

Source: IANS
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All

More News on: